{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T11:50:05Z","timestamp":1790596205990,"version":"4.1.0"},"reference-count":166,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T00:00:00Z","timestamp":1758240000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomolecules"],"abstract":"<jats:p>Alzheimer\u2019s disease (AD) is a progressive neurodegenerative disorder and one of the most pressing global health challenges. Increasing evidence highlights oxidative stress as a key factor in its pathogenesis, contributing to amyloid-\u03b2 accumulation, tau hyperphosphorylation, neuroinflammation, and mitochondrial dysfunction. Oxidative stress markers, detected in the bodily fluids of AD patients, are considered promising diagnostic and prognostic tools. Despite extensive research, currently available therapies remain largely symptomatic, which emphasizes the need to develop novel, disease-modifying strategies. The aim of this review is to summarize current knowledge on the role of oxidative stress in the pathogenesis of AD and to evaluate therapeutic approaches aimed at its reduction. We discuss molecular mechanisms linking reactive oxygen species to neurodegeneration and present pharmacological strategies such as monoamine oxidase inhibitors and multifunctional agents, as well as natural antioxidants, dietary interventions, and novel therapeutic technologies. We pay particular attention to their efficacy, limitations, and translational challenges. A more profound understanding of oxidative stress-related mechanisms may facilitate the development of combined antioxidant, anti-inflammatory, and neuroprotective approaches, offering new perspectives for delaying disease progression and improving patient outcomes.<\/jats:p>","DOI":"10.3390\/biom15091345","type":"journal-article","created":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T16:53:42Z","timestamp":1758300822000},"page":"1345","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Perspectives on Alzheimer\u2019s Disease Treatment Based on Counteracting Oxidative Stress"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5197-4281","authenticated-orcid":false,"given":"Rafa\u0142","family":"Bilski","sequence":"first","affiliation":[{"name":"Department of Medical Biology and Biochemistry, Faculty of Medicine, Ludwik Rydygier Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toru\u0144, 24 Kar\u0142owicza St., 85-092 Bydgoszcz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanis\u0142aw","family":"D\u0105bkowski","sequence":"additional","affiliation":[{"name":"Students Research Club of Medical Biology, Department of Medical Biology and Biochemistry, Faculty of Medicine, Ludwik Rydygier Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toru\u0144, 87-100 Torun, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"Kozie\u0142","sequence":"additional","affiliation":[{"name":"Students Research Club of Medical Biology, Department of Medical Biology and Biochemistry, Faculty of Medicine, Ludwik Rydygier Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toru\u0144, 87-100 Torun, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micha\u0142","family":"Kozicki","sequence":"additional","affiliation":[{"name":"Students Research Club of Medical Biology, Department of Medical Biology and Biochemistry, Faculty of Medicine, Ludwik Rydygier Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toru\u0144, 87-100 Torun, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Ma\u0142achowska","sequence":"additional","affiliation":[{"name":"Students Research Club of Medical Biology, Department of Medical Biology and Biochemistry, Faculty of Medicine, Ludwik Rydygier Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toru\u0144, 87-100 Torun, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miko\u0142aj","family":"Przygocki","sequence":"additional","affiliation":[{"name":"Students Research Club of Medical Biology, Department of Medical Biology and Biochemistry, Faculty of Medicine, Ludwik Rydygier Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toru\u0144, 87-100 Torun, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliwia","family":"Tyska","sequence":"additional","affiliation":[{"name":"Students Research Club of Medical Biology, Department of Medical Biology and Biochemistry, Faculty of Medicine, Ludwik Rydygier Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toru\u0144, 87-100 Torun, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,9,19]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Twiss, E., McPherson, C., and Weaver, D.F. (2025). Global Diseases Deserve Global Solutions: Alzheimer\u2019s Disease. Neurol. Int., 17.","DOI":"10.3390\/neurolint17060092"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.3233\/JAD-170543","article-title":"Oxidative Stress, Amyloid-\u0392 Peptide, and Altered Key Molecular Pathways in the Pathogenesis and Progression of Alzheimer\u2019s Disease","volume":"62","author":"Butterfield","year":"2018","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1146\/annurev-biochem-061516-045037","article-title":"Oxidative Stress","volume":"86","author":"Sies","year":"2017","journal-title":"Annu. Rev. Biochem."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/s41580-024-00730-2","article-title":"Fundamentals of Redox Regulation in Biology","volume":"25","author":"Sies","year":"2024","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/j.1365-2796.2010.02268.x","article-title":"Redox Sensing: Orthogonal Control in Cell Cycle and Apoptosis Signalling","volume":"268","author":"Jones","year":"2010","journal-title":"J. Intern. Med."},{"key":"ref_6","first-page":"86","article-title":"The Biological Pathways of Alzheimer Disease: A Review","volume":"8","author":"Rinaldi","year":"2020","journal-title":"AIMS Neurosci."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Ko\u0142odziejska, R., Wo\u017aniak, A., Bilski, R., Weso\u0142owski, R., Kupczyk, D., Porzych, M., Wr\u00f3blewska, W., and Pawluk, H. (2025). Melatonin\u2014A Powerful Oxidant in Neurodegenerative Diseases. Antioxidants, 14.","DOI":"10.3390\/antiox14070819"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Kabir, M.T., Uddin, M.S., Mamun, A.A., Jeandet, P., Aleya, L., Mansouri, R.A., Ashraf, G.M., Mathew, B., Bin-Jumah, M.N., and Abdel-Daim, M.M. (2020). Combination Drug Therapy for the Management of Alzheimer\u2019s Disease. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21093272"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Naoi, M., Maruyama, W., and Shamoto-Nagai, M. (2022). Neuroprotective Function of Rasagiline and Selegiline, Inhibitors of Type B Monoamine Oxidase, and Role of Monoamine Oxidases in Synucleinopathies. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms231911059"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Collins, A.E., Saleh, T.M., and Kalisch, B.E. (2022). Naturally Occurring Antioxidant Therapy in Alzheimer\u2019s Disease. Antioxidants, 11.","DOI":"10.3390\/antiox11020213"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e70496","DOI":"10.1002\/fsn3.70496","article-title":"Polyphenols and Alzheimer\u2019s Disease: A Review on Molecular and Therapeutic Insights with In Silico Support","volume":"13","author":"Chen","year":"2025","journal-title":"Food Sci. Nutr."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Hu, L., Tao, Y., Jiang, Y., and Qin, F. (2023). Recent Progress of Nanomedicine in the Treatment of Alzheimer\u2019s Disease. Front. Cell Dev. Biol., 11.","DOI":"10.3389\/fcell.2023.1228679"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Teleanu, D.M., Niculescu, A.-G., Lungu, I.I., Radu, C.I., Vlad\u00e2cenco, O., Roza, E., Cost\u0103chescu, B., Grumezescu, A.M., and Teleanu, R.I. (2022). An Overview of Oxidative Stress, Neuroinflammation, and Neurodegenerative Diseases. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23115938"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Misrani, A., Tabassum, S., and Yang, L. (2021). Mitochondrial Dysfunction and Oxidative Stress in Alzheimer\u2019s Disease. Front. Aging Neurosci., 13.","DOI":"10.3389\/fnagi.2021.617588"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"La Torre, A., Lo Vecchio, F., Angelillis, V.S., Gravina, C., D\u2019Onofrio, G., and Greco, A. (2025). Reinforcing NRF2 Signaling: Help in the Alzheimer\u2019s Disease Context. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26031130"},{"key":"ref_16","first-page":"591","article-title":"Preventive and Therapeutic Strategies in Alzheimer\u2019s Disease: Focus on Oxidative Stress, Redox Metals, and Ferroptosis","volume":"34","author":"Perry","year":"2020","journal-title":"Antioxid. Redox Signal."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"519","DOI":"10.3892\/br.2016.630","article-title":"Role of Oxidative Stress in Alzheimer\u2019s Disease","volume":"4","author":"Huang","year":"2016","journal-title":"Biomed. Rep."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"148776","DOI":"10.1016\/j.brainres.2024.148776","article-title":"Oxidative Stress Is Associated with A\u03b2 Accumulation in Chronic Sleep Deprivation Model","volume":"1829","author":"Beiyu","year":"2024","journal-title":"Brain Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3109\/09537104.2012.661104","article-title":"Effects of Oxidative Stress on Amyloid Precursor Protein Processing in Rat and Human Platelets","volume":"24","author":"Ehrlich","year":"2012","journal-title":"Platelets"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.redox.2017.10.014","article-title":"Oxidative Stress and the Amyloid Beta Peptide in Alzheimer\u2019s Disease","volume":"14","author":"Cheignon","year":"2017","journal-title":"Redox Biol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2944","DOI":"10.1021\/acschemneuro.3c00486","article-title":"Oxidative Stress Occurs Prior to Amyloid A\u0392 Plaque Formation and TAU Phosphorylation in Alzheimer\u2019s Disease: Role of Glutathione and Metal Ions","volume":"14","author":"Roy","year":"2023","journal-title":"ACS Chem. Neurosci."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3233\/JAD-201556","article-title":"Copper Imbalance in Alzheimer\u2019s Disease and Its Link with the Amyloid Hypothesis: Towards a Combined Clinical, Chemical, and Genetic Etiology","volume":"83","author":"Squitti","year":"2021","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1002\/alz.12282","article-title":"Regional Brain Iron Associated with Deterioration in Alzheimer\u2019s Disease: A Large Cohort Study and Theoretical Significance","volume":"17","author":"Ayton","year":"2021","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1515\/revneuro-2018-0008","article-title":"Role of P38\/MAPKs in Alzheimer\u2019s Disease: Implications for Amyloid Beta Toxicity Targeted Therapy","volume":"30","author":"Kheiri","year":"2018","journal-title":"Rev. Neurosci."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Detka, J., P\u0142achtij, N., Strzelec, M., Manik, A., and Sa\u0142at, K. (2024). P38\u03b1 Mitogen-Activated Protein Kinase\u2014An Emerging Drug Target for the Treatment of Alzheimer\u2019s Disease. Molecules, 29.","DOI":"10.3390\/molecules29184354"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Fu\u0142ek, M., Hachiya, N., Gachowska, M., Besz\u0142ej, J.A., Bartoszewska, E., Kurpas, D., Kurpi\u0144ski, T., Adamska, H., Por\u0119ba, R., and Urban, S. (2025). Cellular Prion Protein and Amyloid-\u0392 Oligomers in Alzheimer\u2019s Disease\u2014Are There Connections?. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26052097"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Pe\u00f1a-Bautista, C., Tirle, T., L\u00f3pez-Nogueroles, M., Vento, M., Baquero, M., and Ch\u00e1fer-Peric\u00e1s, C. (2019). Oxidative Damage of DNA as Early Marker of Alzheimer\u2019s Disease. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20246136"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.neures.2021.11.009","article-title":"Deficiency of MTH1 and\/or OGG1 Increases the Accumulation of 8-Oxoguanine in the Brain of the AppNL-G-F\/NL-G-F Knock-in Mouse Model of Alzheimer\u2019s Disease, Accompanied by Accelerated Microgliosis and Reduced Anxiety-like Behavior","volume":"177","author":"Mizuno","year":"2021","journal-title":"Neurosci. Res."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Kim, S., Jung, U.J., and Kim, S.R. (2024). Role of Oxidative Stress in Blood\u2013Brain Barrier Disruption and Neurodegenerative Diseases. Antioxidants, 13.","DOI":"10.3390\/antiox13121462"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.3233\/JAD-180098","article-title":"Role of Blood-Brain Barrier in Alzheimer\u2019s Disease","volume":"63","author":"Cai","year":"2018","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Kerr, F., Sofola-Adesakin, O., Ivanov, D.K., Gatliff, J., Perez-Nievas, B.G., Bertrand, H.C., Martinez, P., Callard, R., Snoeren, I., and Cochem\u00e9, H.M. (2017). Direct Keap1-Nrf2 Disruption as a Potential Therapeutic Target for Alzheimer\u2019s Disease. PLoS Genet., 13.","DOI":"10.1371\/journal.pgen.1006593"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"9971885","DOI":"10.1155\/2021\/9971885","article-title":"Redox Homeostasis and Prospects for Therapeutic Targeting in Neurodegenerative Disorders","volume":"2021","author":"Akanji","year":"2021","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1007\/s11064-007-9453-3","article-title":"Lipid Peroxidation and Antioxidant Enzyme Activities in Vascular and Alzheimer Dementias","volume":"33","author":"Casado","year":"2007","journal-title":"Neurochem. Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/agm2.12173","article-title":"Serum Apelin-13 Levels and Total Oxidant\/Antioxidant Status of Patients with Alzheimer\u2019s Disease","volume":"4","author":"Yildiz","year":"2021","journal-title":"Aging Med."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Socha, K., Klimiuk, K., Naliwajko, S.K., Soroczy\u0144ska, J., Pu\u015bcion-Jakubik, A., Markiewicz-\u017bukowska, R., and Kochanowicz, J. (2021). Dietary Habits, Selenium, Copper, Zinc and Total Antioxidant Status in Serum in Relation to Cognitive Functions of Patients with Alzheimer\u2019s Disease. Nutrients, 13.","DOI":"10.3390\/nu13020287"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Nie, Y., Chu, C., Qin, Q., Shen, H., Wen, L., Tang, Y., and Qu, M. (2023). Lipid Metabolism and Oxidative Stress in Patients with Alzheimer\u2019s Disease and Amnestic Mild Cognitive Impairment. Brain Pathol., 34.","DOI":"10.1111\/bpa.13202"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.neulet.2005.12.017","article-title":"Elevated Protein-Bound Levels of the Lipid Peroxidation Product, 4-Hydroxy-2-Nonenal, in Brain from Persons with Mild Cognitive Impairment","volume":"397","author":"Butterfield","year":"2006","journal-title":"Neurosci. Lett."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1212\/01.WNL.0000156156.13641.BA","article-title":"Evidence of Increased Oxidative Damage in Subjects with Mild Cognitive Impairment","volume":"64","author":"Keller","year":"2005","journal-title":"Neurology"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3233\/JAD-190198","article-title":"Altered Redox State in Whole Blood Cells from Patients with Mild Cognitive Impairment and Alzheimer\u2019s Disease","volume":"71","author":"Vida","year":"2019","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/NEN.0b013e3181cb5af4","article-title":"Oxidative Stress in the Progression of Alzheimer Disease in the Frontal Cortex","volume":"69","author":"Ansari","year":"2010","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.brainres.2009.04.009","article-title":"Proteomic Identification of HNE-Bound Proteins in Early Alzheimer Disease: Insights into the Role of Lipid Peroxidation in the Progression of AD","volume":"1274","author":"Reed","year":"2009","journal-title":"Brain Res."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13195-022-00961-5","article-title":"Altered Central and Blood Glutathione in Alzheimer\u2019s Disease and Mild Cognitive Impairment: A Meta-Analysis","volume":"14","author":"Chen","year":"2022","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1089\/ars.2020.8129","article-title":"Glutathione: An Old and Small Molecule with Great Functions and New Applications in the Brain and in Alzheimer\u2019s Disease","volume":"35","author":"Haddad","year":"2021","journal-title":"Antioxid. Redox Signal."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1177\/13872877251346981","article-title":"Glutathione Peroxidase Activity in Alzheimer\u2019s Disease Patients: A Systematic Review and Meta-Analysis","volume":"106","author":"Pereira","year":"2025","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1111\/ggi.12361","article-title":"Ischemia-modified Albumin and Advanced Oxidation Protein Products as Potential Biomarkers of Protein Oxidation in Alzheimer\u2019s Disease","volume":"15","author":"Altunoglu","year":"2014","journal-title":"Geriatr. Gerontol. Int."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1744-9081-2-15","article-title":"Melatonin in Alzheimer\u2019s Disease and Other Neurodegenerative Disorders","volume":"2","author":"Srinivasan","year":"2006","journal-title":"Behav. Brain Funct."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13195-021-00788-6","article-title":"Melatonin Levels in the Alzheimer\u2019s Disease Continuum: A Systematic Review","volume":"13","author":"Nous","year":"2021","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"247","DOI":"10.7861\/clinmedicine.16-3-247","article-title":"Drug treatments in Alzheimer\u2019s disease","volume":"16","author":"Briggs","year":"2016","journal-title":"Clin. Med."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Li, D.D., Zhang, Y.H., Zhang, W., and Zhao, P. (2019). Meta-analysis of randomized controlled trials on the efficacy and safety of donepezil, galantamine, rivastigmine, and memantine for the treatment of Alzheimer\u2019s disease. Front. Neurosci., 13.","DOI":"10.3389\/fnins.2019.00472"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"e12465","DOI":"10.1002\/trc2.12465","article-title":"Alzheimer\u2019s disease drug development pipeline: 2024","volume":"10","author":"Cummings","year":"2024","journal-title":"Transl. Res. Clin. Interv."},{"key":"ref_51","first-page":"109","article-title":"Defining disease modifying therapy for Alzheimer\u2019s disease","volume":"4","author":"Cummings","year":"2017","journal-title":"J. Prev. Alzheimer\u2019s Dis."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"779","DOI":"10.3233\/JAD-180766","article-title":"Treatment combinations for Alzheimer\u2019s disease: Current and future pharmacotherapy options","volume":"67","author":"Cummings","year":"2019","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1038\/jcbfm.2013.19","article-title":"Distribution of monoamine oxidase proteins in human brain: Implications for brain imaging studies","volume":"33","author":"Tong","year":"2013","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Chaurasiya, N.D., Leon, F., Muhammad, I., and Tekwani, B.L. (2022). Natural Products Inhibitors of Monoamine Oxidases\u2014Potential New Drug Leads for Neuroprotection, Neurological Disorders, and Neuroblastoma. Molecules, 27.","DOI":"10.3390\/molecules27134297"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/j.addr.2008.06.002","article-title":"Monoamine oxidase inactivation: From pathophysiology to therapeutics","volume":"60","author":"Bortolato","year":"2008","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/WNF.0000000000000239","article-title":"A Randomized Double-Blind Placebo-Controlled Phase III Trial of Selegiline Monotherapy for Early Parkinson Disease","volume":"40","author":"Mizuno","year":"2017","journal-title":"Clin. Neuropharmacol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.parkreldis.2018.08.024","article-title":"Rasagiline monotherapy in early Parkinson\u2019s disease: A phase 3, randomized study in Japan","volume":"60","author":"Hattori","year":"2019","journal-title":"Park. Relat. Disord."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1176\/appi.ajp.159.11.1869","article-title":"Transdermal selegiline in major depression: A double-blind, placebo-controlled, parallel-group study in outpatients","volume":"159","author":"Bodkin","year":"2002","journal-title":"Am. J. Psychiatry"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1007\/s12035-024-04388-x","article-title":"Selegiline improves cognitive impairment in the rat model of Alzheimer\u2019s disease","volume":"62","author":"Basir","year":"2024","journal-title":"Mol. Neurobiol."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Cai, M., and Yang, E.J. (2020). Effect of combined electroacupuncture and selegiline treatment in Alzheimer\u2019s disease: An animal model. Front. Pharmacol., 11.","DOI":"10.3389\/fphar.2020.606480"},{"key":"ref_61","first-page":"234","article-title":"Selegiline in the treatment of Alzheimer\u2019s disease: A long-term randomized placebo-controlled trial. Czech and Slovak Senile Dementia of Alzheimer Type Study Group","volume":"24","author":"Filip","year":"1999","journal-title":"J. Psychiatry Neurosci."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1007\/s002280050702","article-title":"Selegiline treatment and the extent of degenerative changes in brain tissue of patients with Alzheimer\u2019s disease","volume":"55","author":"Alafuzoff","year":"2000","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1016\/j.neurobiolaging.2015.05.009","article-title":"Effect of long-term treatment with rasagiline on cognitive deficits and neuroprotection in aged mice","volume":"36","author":"Weinreb","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1177\/0284185120940264","article-title":"Possible neuroprotective effects of rasagiline in Alzheimer\u2019s disease: A SPECT study","volume":"62","author":"Song","year":"2020","journal-title":"Acta Radiol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/jnr.20350","article-title":"Rasagiline: Neurodegeneration, neuroprotection, and mitochondrial permeability transition","volume":"79","author":"Youdim","year":"2005","journal-title":"J. Neurosci. Res."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.neurobiolaging.2009.06.004","article-title":"Ladostigil prevents age-related glial activation and spatial memory deficits in rats","volume":"32","author":"Weinstock","year":"2011","journal-title":"Neurobiol. Aging"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"108229","DOI":"10.1016\/j.neuropharm.2020.108229","article-title":"Effect of ladostigil treatment of aging rats on gene expression in four brain areas associated with regulation of memory","volume":"177","author":"Linial","year":"2020","journal-title":"Neuropharm."},{"key":"ref_68","first-page":"e1474","article-title":"Low-dose ladostigil for mild cognitive impairment. A phase 2 placebo-controlled clinical trial","volume":"93","author":"Schneider","year":"2019","journal-title":"Neuropharmacology"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/B978-0-12-386467-3.00009-1","article-title":"Selective inhibitors of monoamine oxidase type B and the \u201ccheese effect\u201d","volume":"100","author":"Finberg","year":"2011","journal-title":"Int. Rev. Neurobiol."},{"key":"ref_70","first-page":"1254","article-title":"Combination of Escitalopram and Rasagiline Induced Serotonin Syndrome: A Case Report and Review Literature","volume":"98","author":"Suphanklang","year":"2015","journal-title":"J. Med. Assoc. Thai."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Nemet, M., Andrijevi\u0107, A., Nedeljkov, \u0110., Andri\u0107, V., and Gavrilovi\u0107, S. (2023). A Case Report on Serotonin Syndrome in a Patient With Parkinson\u2019s Disease: Diagnostic and Management Challenges. Cureus, 15.","DOI":"10.7759\/cureus.36780"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"91","DOI":"10.4103\/0253-7613.174573","article-title":"Linezolid and Rasagiline\u2014A culprit for serotonin syndrome","volume":"48","author":"Hisham","year":"2016","journal-title":"Indian J. Pharmacol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1002\/phar.1500","article-title":"Serotonin toxicity association with concomitant antidepressants and rasagiline treatment: Retrospective study (STACCATO)","volume":"34","author":"Panisset","year":"2014","journal-title":"Pharmacotherapy"},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Yu, T.-W., Lane, H.-Y., and Lin, C.-H. (2021). Novel Therapeutic Approaches for Alzheimer\u2019s Disease: An Updated Review. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22158208"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/s41392-024-01911-3","article-title":"Recent Advances in Alzheimer\u2019s Disease: Mechanisms, Clinical Trials and New Drug Development Strategies","volume":"9","author":"Zhang","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Doroszkiewicz, J., and Mroczko, B. (2022). New Possibilities in the Therapeutic Approach to Alzheimer\u2019s Disease. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23168902"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s13195-020-00663-w","article-title":"Aducanumab, Gantenerumab, BAN2401, and ALZ-801\u2014The First Wave of Amyloid-Targeting Drugs for Alzheimer\u2019s Disease with Potential for near Term Approval","volume":"12","author":"Tolar","year":"2020","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1001\/jama.2023.13239","article-title":"Donanemab in Early Symptomatic Alzheimer Disease","volume":"330","author":"Sims","year":"2023","journal-title":"JAMA"},{"key":"ref_79","first-page":"495","article-title":"Alzheimer Drug Lecanemab Gains Traditional FDA Approval","volume":"330","author":"Harris","year":"2023","journal-title":"JAMA"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.2217\/imt-2016-0019","article-title":"Tau-Based Therapeutics for Alzheimer\u2019s Disease: Active and Passive Immunotherapy","volume":"8","author":"Panza","year":"2016","journal-title":"Immunotherapy"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/s41582-018-0013-z","article-title":"Tau-Targeting Therapies for Alzheimer Disease","volume":"14","author":"Congdon","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1080\/13543784.2019.1619694","article-title":"Tau Immunotherapies for Alzheimer\u2019s Disease","volume":"28","author":"Hoskin","year":"2019","journal-title":"Expert Opin. Investig. Drugs"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.jphs.2020.05.009","article-title":"Inhibition of STAT3 Phosphorylation Attenuates Impairments in Learning and Memory in 5XFAD Mice, an Animal Model of Alzheimer\u2019s Disease","volume":"143","author":"Choi","year":"2020","journal-title":"J. Pharmacol. Sci."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.imlet.2020.10.004","article-title":"STAT3 Inhibition Protects against Neuroinflammation and BACE1 Upregulation Induced by Systemic Inflammation","volume":"228","author":"Millot","year":"2020","journal-title":"Immunol. Lett."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1093\/brain\/awv379","article-title":"Pharmacological Targeting of CSF1R Inhibits Microglial Proliferation and Prevents the Progression of Alzheimer\u2019s-like Pathology","volume":"139","author":"Schetters","year":"2016","journal-title":"Brain"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1093\/brain\/awz241","article-title":"CSF1R Inhibitor JNJ-40346527 Attenuates Microglial Proliferation and Neurodegeneration in P301S Mice","volume":"142","author":"Mancuso","year":"2019","journal-title":"Brain"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13024-018-0244-x","article-title":"Early Long-Term Administration of the CSF1R Inhibitor PLX3397 Ablates Microglia and Reduces Accumulation of Intraneuronal Amyloid, Neuritic Plaque Deposition and Pre-Fibrillar Oligomers in 5XFAD Mouse Model of Alzheimer\u2019s Disease","volume":"13","author":"Sosna","year":"2018","journal-title":"Mol. Neurodegener."},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Gejl, M., Gjedde, A., Egefjord, L., M\u00f8ller, A., Hansen, S.B., Vang, K., Rodell, A., Br\u00e6ndgaard, H., Gottrup, H., and Schacht, A. (2016). In Alzheimer\u2019s Disease, 6-Month Treatment with GLP-1 Analog Prevents Decline of Brain Glucose Metabolism: Randomized, Placebo-Controlled, Double-Blind Clinical Trial. Front. Aging Neurosci., 8.","DOI":"10.3389\/fnagi.2016.00108"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.biopsych.2013.08.010","article-title":"Benzoate, a D-Amino Acid Oxidase Inhibitor, for the Treatment of Early-Phase Alzheimer Disease: A Randomized, Double-Blind, Placebo-Controlled Trial","volume":"75","author":"Lin","year":"2013","journal-title":"Biol. Psychiatry"},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Lin, C.-H., Chen, P.-K., Wang, S.-H., and Lane, H.-Y. (2021). Effect of Sodium Benzoate on Cognitive Function among Patients with Behavioral and Psychological Symptoms of Dementia. JAMA Netw. Open, 4.","DOI":"10.1001\/jamanetworkopen.2021.6156"},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Georgieva, D., Nikolova, D., Vassileva, E., and Kostova, B. (2023). Chitosan-Based Nanoparticles for Targeted Nasal Galantamine Delivery as a Promising Tool in Alzheimer\u2019s Disease Therapy. Pharmaceutics, 15.","DOI":"10.3390\/pharmaceutics15030829"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"102291","DOI":"10.1016\/j.arr.2024.102291","article-title":"Treating Alzheimer\u2019s Disease Using Nanoparticle-Mediated Drug Delivery Strategies\/Systems","volume":"97","author":"Roghani","year":"2024","journal-title":"Ageing Res. Rev."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"4031","DOI":"10.1039\/D4RA08128E","article-title":"Nanoscale Drug Formulations for the Treatment of Alzheimer\u2019s Disease Progression","volume":"15","author":"Liu","year":"2025","journal-title":"RSC Adv."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s11064-022-03722-w","article-title":"Scrutinizing the Therapeutic Potential of PROTACs in the Management of Alzheimer\u2019s Disease","volume":"48","author":"Bhatia","year":"2022","journal-title":"Neurochem. Res."},{"key":"ref_95","first-page":"24","article-title":"PROTAC Technology for the Treatment of Alzheimer\u2019s Disease: Advances and Perspectives","volume":"1","author":"Inuzuka","year":"2022","journal-title":"Acta Mater. Medica"},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Kong, D., Meng, L., Lin, P., and Wu, G. (2025). Advancements in PROTAC-Based Therapies for Neurodegenerative Diseases. Future Med. Chem., 591\u2013605.","DOI":"10.1080\/17568919.2025.2463310"},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Roberts, W.S., Price, S., Wu, M., and Parmar, M.S. (2024). Emerging Gene Therapies for Alzheimer\u2019s and Parkinson\u2019s Diseases: An Overview of Clinical Trials and Promising Candidates. Cureus, 16.","DOI":"10.7759\/cureus.67037"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"S417","DOI":"10.3233\/JAD-230783","article-title":"Advances and Challenges in Gene Therapy for Alzheimer\u2019s Disease","volume":"101","author":"Morroni","year":"2024","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1007\/s12035-024-04285-3","article-title":"From Lab Bench to Hope: Emerging Gene Therapies in Clinical Trials for Alzheimer\u2019s Disease","volume":"62","author":"Ortega","year":"2024","journal-title":"Mol. Neurobiol."},{"key":"ref_100","first-page":"1664","article-title":"Natural antioxidants that act against Alzheimer\u2019s disease through modulation of the NRF2 pathway: A focus on their molecular mechanisms of action","volume":"14","author":"Sidiropoulou","year":"2023","journal-title":"Frontiers"},{"key":"ref_101","first-page":"2314","article-title":"Effects of Resveratrol on the Mechanisms of Antioxidants and Estrogen in Alzheimer\u2019s Disease","volume":"1","author":"Kong","year":"2019","journal-title":"BioMed Res. Int."},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Jakubczyk, K., Dru\u017cga, A., Katarzyna, J., and Skonieczna-\u017bydecka, K. (2020). Antioxidant Potential of Curcumin\u2014A Meta-Analysis of Randomized Clinical Trials. Antioxidants, 9.","DOI":"10.3390\/antiox9111092"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s12013-009-9043-x","article-title":"A review of the antioxidant mechanisms of polyphenol compounds related to iron binding","volume":"53","author":"Perron","year":"2009","journal-title":"Cell Biochem. Biophys."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1093\/ajcn\/71.2.630s","article-title":"Vitamin E and Alzheimer disease: The basis for additional clinical trials","volume":"71","author":"Grundman","year":"2000","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1006\/exnr.1994.1002","article-title":"Vitamin E Prevents the Place Learning Deficit and the Cholinergic Hypofunction Induced by AF64A","volume":"125","author":"Stackman","year":"1994","journal-title":"Exp. Neurol."},{"key":"ref_106","first-page":"1663","article-title":"A quantitative meta-analysis of vitamin C in the pathophysiology of Alzheimer\u2019s disease","volume":"14","author":"Hamid","year":"2022","journal-title":"Frontiers"},{"key":"ref_107","first-page":"4037","article-title":"An Overview of the Characteristics and Function of Vitamin C in Various Tissues: Relying on its Antioxidant Function","volume":"18","author":"Akbari","year":"2016","journal-title":"Zahedan J. Res. Med. Sci."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1111\/1750-3841.14284","article-title":"Antioxidant Properties and Phenolic Compounds of Vitamin C-Rich Juices","volume":"83","author":"Nowak","year":"2018","journal-title":"J. Food Sci."},{"key":"ref_109","first-page":"1475","article-title":"Potential neuroprotective properties of epigallocatechin-3-gallate (EGCG)","volume":"15","author":"Singh","year":"2016","journal-title":"Nutr. J."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.2147\/DDDT.S289473","article-title":"Epigallocatechin-3-Gallate Provides Protection against Alzheimer\u2019s Disease-Induced Learning and Memory Impairments in Rats","volume":"15","author":"Nan","year":"2021","journal-title":"Drug Des. Devel. Ther."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1002\/fsn3.3888","article-title":"Isolation of phenolic compounds from eco-friendly white bee propolis: Antioxidant, wound-healing, and anti-Alzheimer effects","volume":"12","author":"Necip","year":"2024","journal-title":"Food Sci. Nutr."},{"key":"ref_112","first-page":"1758","article-title":"Oral curcumin for Alzheimer\u2019s disease: Tolerability and efficacy in a 24-week randomized, double blind, placebo-controlled study","volume":"4","author":"Ringman","year":"2012","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1007\/s10787-024-01442-x","article-title":"Neuroprotective Effects of Rutin against Cuprizone-Induced Multiple Sclerosis in Mice","volume":"32","author":"Nicola","year":"2024","journal-title":"Inflammopharmacology"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"73","DOI":"10.4103\/JAPTR.JAPTR_313_24","article-title":"Potential of Rutin from Rhizophora Mucronata Leaves as a Inhibitor of Kelch-like ECH-Associated Protein 1\/Nuclear Factor Erythroid 2 Related Factor 2 Keap1\/Nrf2): An in Silico Study for Alzheimer\u2019s Therapy","volume":"16","author":"Saputri","year":"2025","journal-title":"J. Adv. Pharm. Technol. Res."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.neuroscience.2012.02.046","article-title":"Rutin Prevents Cognitive Impairments by Ameliorating Oxidative Stress and Neuroinflammation in Rat Model of Sporadic Dementia of Alzheimer Type","volume":"210","author":"Javed","year":"2012","journal-title":"Neuroscience"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s12974-021-02182-3","article-title":"Rutin Prevents Tau Pathology and Neuroinflammation in a Mouse Model of Alzheimer\u2019s Disease","volume":"18","author":"Sun","year":"2021","journal-title":"J. Neuroinflamm."},{"key":"ref_117","doi-asserted-by":"crossref","unstructured":"Kim, J. (2021). Pre-Clinical Neuroprotective Evidences and Plausible Mechanisms of Sulforaphane in Alzheimer\u2019s Disease. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22062929"},{"key":"ref_118","doi-asserted-by":"crossref","unstructured":"Fahey, J.W., Liu, H., Batt, H., Panjwani, A.A., and Tsuji, P. (2025). Sulforaphane and Brain Health: From Pathways of Action to Effects on Specific Disorders. Nutrients, 17.","DOI":"10.3390\/nu17081353"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1800240","DOI":"10.1002\/mnfr.201800240","article-title":"Sulforaphane Upregulates the Heat Shock Protein Co-Chaperone CHIP and Clears amyloid-\u0392 and TAU in a Mouse Model of Alzheimer\u2019s Disease","volume":"62","author":"Lee","year":"2018","journal-title":"Mol. Nutr. Food Res."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"12516","DOI":"10.1073\/pnas.1819541116","article-title":"NRF2\/ARE Pathway Negatively Regulates BACE1 Expression and Ameliorates Cognitive Deficits in Mouse Alzheimer\u2019s Models","volume":"116","author":"Bahn","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.3233\/JAD-171110","article-title":"Sulforaphane Inhibits the Generation of Amyloid-\u0392 Oligomer and Promotes Spatial Learning and Memory in Alzheimer\u2019s Disease (PS1V97L) Transgenic Mice","volume":"62","author":"Hou","year":"2018","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_122","doi-asserted-by":"crossref","unstructured":"Zhang, J., Zhang, R., Zhan, Z., Li, X., Zhou, F., Xing, A., Jiang, C., Chen, Y., and An, L. (2017). Beneficial Effects of Sulforaphane Treatment in Alzheimer\u2019s Disease May Be Mediated through Reduced HDAC1\/3 and Increased P75NTR Expression. Front. Aging Neurosci., 9.","DOI":"10.3389\/fnagi.2017.00121"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/s40203-024-00267-4","article-title":"Molecular Mechanisms of Sulforaphane in Alzheimer\u2019s Disease: Insights from an in-Silico Study","volume":"12","author":"Vu","year":"2024","journal-title":"Silico Pharmacol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"11139","DOI":"10.18632\/aging.103328","article-title":"Melatonin Regulates Mitochondrial Dynamics and Alleviates Neuron Damage in Prion Diseases","volume":"12","author":"Zhang","year":"2020","journal-title":"Aging"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1159\/000494889","article-title":"Neuroendocrine-Metabolic Dysfunction and Sleep Disturbances in Neurodegenerative Disorders: Focus on Alzheimer\u2019s Disease and Melatonin","volume":"108","author":"Spinedi","year":"2018","journal-title":"Neuroendocrinology"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"S193","DOI":"10.3233\/JAD-230760","article-title":"Melatonin in Alzheimer\u2019s Disease: Literature Review and Therapeutic Trials","volume":"101","author":"Steinbach","year":"2024","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.2174\/1570159X15666170313123454","article-title":"Mechanisms of Melatonin in Alleviating Alzheimer\u2019s Disease","volume":"15","author":"Shukla","year":"2017","journal-title":"Curr. Neuropharmacol."},{"key":"ref_128","doi-asserted-by":"crossref","unstructured":"Tiong, Y.L., Ng, K.Y., Koh, R.Y., Ponnudurai, G., and Chye, S.M. (2019). Melatonin Prevents Oxidative Stress-Induced Mitochondrial Dysfunction and Apoptosis in High Glucose-Treated Schwann Cells via Upregulation of BCL2, NF-\u039aB, MTOR, WNT Signalling Pathways. Antioxidants, 8.","DOI":"10.3390\/antiox8070198"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"3804","DOI":"10.12659\/MSM.907734","article-title":"Melatonin Treatment Regulates SIRT3 Expression in Early Brain Injury (EBI) Due to Reactive Oxygen Species (ROS) in a Mouse Model of Subarachnoid Hemorrhage (SAH)","volume":"24","author":"Yang","year":"2018","journal-title":"Med. Sci. Monit."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"e13704","DOI":"10.1111\/acel.13704","article-title":"Importance of Bmal1 in Alzheimer\u2019s Disease and Associated Aging-related Diseases: Mechanisms and Interventions","volume":"21","author":"Fan","year":"2022","journal-title":"Aging Cell"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"795","DOI":"10.3233\/JAD-200331","article-title":"The Rhythmicity of Clock Genes Is Disrupted in the Choroid Plexus of the APP\/PS1 Mouse Model of Alzheimer\u2019s Disease","volume":"77","author":"Furtado","year":"2020","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1007\/s10787-023-01181-5","article-title":"Melatonin Suppresses Inflammation and Blood\u2014Brain Barrier Disruption in Rats with Vascular Dementia Possibly by Activating the SIRT1\/PGC-1\u03b1\/PPAR\u03b3 Signaling Pathway","volume":"31","author":"Thangwong","year":"2023","journal-title":"Inflammopharmacology"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13041-017-0315-x","article-title":"The Role of Melatonin in the Onset and Progression of Type 3 Diabetes","volume":"10","author":"Song","year":"2017","journal-title":"Mol. Brain"},{"key":"ref_134","doi-asserted-by":"crossref","unstructured":"Burillo, J., Marqu\u00e9s, P., Jim\u00e9nez, B., Gonz\u00e1lez-Blanco, C., Benito, M., and Guill\u00e9n, C. (2021). Insulin Resistance and Diabetes Mellitus in Alzheimer\u2019s Disease. Cells, 10.","DOI":"10.3390\/cells10051236"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"100050","DOI":"10.1016\/j.nbas.2022.100050","article-title":"Sleep, Sirtuin 1 and Alzheimer\u2019s Disease: A Review","volume":"2","author":"Mehramiz","year":"2022","journal-title":"Aging Brain"},{"key":"ref_136","doi-asserted-by":"crossref","unstructured":"Chen, D., Zhang, T., and Lee, T.H. (2020). Cellular Mechanisms of Melatonin: Insight from Neurodegenerative Diseases. Biomolecules, 10.","DOI":"10.3390\/biom10081158"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1021\/acschemneuro.7b00278","article-title":"Melatonin Improves Cognitive Deficits via Restoration of Cholinergic Dysfunction in a Mouse Model of Scopolamine-Induced Amnesia","volume":"9","author":"Chen","year":"2017","journal-title":"ACS Chem. Neurosci."},{"key":"ref_138","doi-asserted-by":"crossref","unstructured":"Cach\u00e1n-Vega, C., Vega-Naredo, I., Potes, Y., Bermejo-Millo, J.C., Rubio-Gonz\u00e1lez, A., Garc\u00eda-Gonz\u00e1lez, C., Antu\u00f1a, E., Berm\u00fadez, M., Guti\u00e9rrez-Rodr\u00edguez, J., and Boga, J.A. (2022). Chronic Treatment with Melatonin Improves Hippocampal Neurogenesis in the Aged Brain and Under Neurodegeneration. Molecules, 27.","DOI":"10.3390\/molecules27175543"},{"key":"ref_139","doi-asserted-by":"crossref","unstructured":"Alkandari, A.F., Madhyastha, S., and Rao, M.S. (2023). N-Acetylcysteine Amide against A\u03b2-Induced Alzheimer\u2019s-like Pathology in Rats. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241612733"},{"key":"ref_140","doi-asserted-by":"crossref","unstructured":"Ontawong, A., Nehra, G., Maloney, B.J., Vaddhanaphuti, C.S., Bauer, B., and Hartz, A.M.S. (2025). N-Acetylcysteine Attenuates A\u0392-Mediated Oxidative Stress, Blood\u2013Brain Barrier Leakage, and Renal Dysfunction in 5xFAD Mice. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26094352"},{"key":"ref_141","doi-asserted-by":"crossref","unstructured":"Ten\u00f3rio, M.C.d.S., Graciliano, N.G., Moura, F.A., de Oliveira, A.C.M., and Goulart, M.O.F. (2021). N-Acetylcysteine (NAC): Impacts on Human Health. Antioxidants, 10.","DOI":"10.3390\/antiox10060967"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.brainresbull.2017.04.001","article-title":"Influence of N-Acetyl Cysteine on Beta-Amyloid-Induced Alzheimer\u2019s Disease in a Rat Model: A Behavioral and Electrophysiological Study","volume":"131","author":"Shahidi","year":"2017","journal-title":"Brain Res. Bull."},{"key":"ref_143","doi-asserted-by":"crossref","unstructured":"Joy, T., Rao, M.S., and Madhyastha, S. (2018). N-Acetyl Cysteine Supplement Minimize TAU Expression and Neuronal Loss in Animal Model of Alzheimer\u2019s Disease. Brain Sci., 8.","DOI":"10.3390\/brainsci8100185"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s40035-023-00336-2","article-title":"Combined Metabolic Activators Improve Cognitive Functions in Alzheimer\u2019s Disease Patients: A Randomised, Double-Blinded, Placebo-Controlled Phase-II Trial","volume":"12","author":"Yulug","year":"2023","journal-title":"Transl. Neurodegener."},{"key":"ref_145","doi-asserted-by":"crossref","unstructured":"Mart\u00ednez, S.M.L., Mois\u00e9s, F.P.P., Bitzer-Quintero, O.K., Ram\u00edrez-Jirano, J., Delgado-Lara, D.L.C., Trujillo, I.C., Jasso, J.H.T., Salazar-Flores, J., and Torres-S\u00e1nchez, E.D. (2025). Effect of N-Acetyl Cysteine as an Adjuvant Treatment in Alzheimer\u2019s Disease. Brain Sci., 15.","DOI":"10.3390\/brainsci15020164"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"148518","DOI":"10.1016\/j.brainres.2023.148518","article-title":"Astaxanthin Enhances Autophagy, Amyloid Beta Clearance and Exerts Anti-Inflammatory Effects in in Vitro Models of Alzheimer\u2019s Disease-Related Blood Brain Barrier Dysfunction and Inflammation","volume":"1819","author":"Babalola","year":"2023","journal-title":"Brain Res."},{"key":"ref_147","doi-asserted-by":"crossref","unstructured":"Liu, N., Lyu, X., Zhang, X., Zhang, F., Chen, Y., and Li, G. (2023). Astaxanthin Attenuates Cognitive Deficits in Alzheimer\u2019s Disease Models by Reducing Oxidative Stress via the SIRT1\/PGC-1\u03b1 Signaling Pathway. Cell Biosci., 13.","DOI":"10.1186\/s13578-023-01129-w"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"103","DOI":"10.17712\/nsj.2024.2.20230060","article-title":"The Protective Effect of Astaxanthin on Scopolamine\u2014Induced Alzheimer\u2019s Model in Mice","volume":"29","author":"Magadmi","year":"2024","journal-title":"Neurosciences"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s11011-025-01560-7","article-title":"Astaxanthin Nanoemulsion Improves Cognitive Function and Synaptic Integrity in Streptozotocin-Induced Alzheimer\u2019s Disease Model","volume":"40","author":"Chik","year":"2025","journal-title":"Metab. Brain Dis."},{"key":"ref_150","doi-asserted-by":"crossref","unstructured":"Balendra, V., and Singh, S.K. (2021). Therapeutic Potential of Astaxanthin and Superoxide Dismutase in Alzheimer\u2019s Disease. Open Biol., 11.","DOI":"10.1098\/rsob.210013"},{"key":"ref_151","doi-asserted-by":"crossref","unstructured":"Yazdi, F.R., Taghizadeh, F., Parvari, S., Javanbakht, P., Mojaverrostami, S., Zarini, D., and Kashani, I.R. (2025). Astaxanthin as an Adjunct Therapy in Alzheimer\u2019s Disease and Multiple Sclerosis: Neuroprotective Mechanisms and Future Perspective. Nutr. Neurosci., 1\u201325.","DOI":"10.1080\/1028415X.2025.2516620"},{"key":"ref_152","first-page":"100226","article-title":"Astaxanthin and Improvement of Dementia: A Systematic Review of Current Clinical Trials","volume":"7","author":"Utomo","year":"2024","journal-title":"Cereb. Circ. Cogn. Behav."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1007\/s11010-021-04079-4","article-title":"Ameliorative Effects of Astaxanthin on Brain Tissues of Alzheimer\u2019s Disease-like Model: Cross Talk between Neuronal-Specific microRNA-124 and Related Pathways","volume":"476","author":"Hafez","year":"2021","journal-title":"Mol. Cell. Biochem."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1007\/s11051-022-05572-7","article-title":"Mesoporous Selenium Nanoparticles for Therapeutic Goals: A Review","volume":"24","author":"Asl","year":"2022","journal-title":"J. Nanoparticle Res."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"104062","DOI":"10.1016\/j.drudis.2024.104062","article-title":"Selenium-Containing Compounds: A New Hope for Innovative Treatments in Alzheimer\u2019s Disease and Parkinson\u2019s Disease","volume":"29","author":"Pyka","year":"2024","journal-title":"Drug Discov. Today"},{"key":"ref_156","first-page":"125519","article-title":"Unravelling the in Vitro and in Vivo Potential of Selenium Nanoparticles in Alzheimer\u2019s Disease: A Bioanalytical Review","volume":"269","year":"2023","journal-title":"Talanta"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s10068-023-01465-0","article-title":"Effect of MIND diet on cognitive function in elderly: A narrative review with emphasis on bioactive food ingredients","volume":"33","author":"Seo","year":"2024","journal-title":"Food Sci. Biotechnol."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1212\/WNL.0000000000004815","article-title":"Nutrients and bioactives in green leafy vegetables and cognitive decline: Prospective study","volume":"90","author":"Morris","year":"2018","journal-title":"Neurology"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/ana.23594","article-title":"Dietary intakes of berries and flavonoids in relation to cognitive decline","volume":"72","author":"Devore","year":"2012","journal-title":"Ann. Neurol."},{"key":"ref_160","doi-asserted-by":"crossref","unstructured":"Omar, S.H. (2019). Mediterranean and MIND Diets Containing Olive Biophenols Reduces the Prevalence of Alzheimer\u2019s Disease. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20112797"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1017\/S0029665121003700","article-title":"Fish, n-3 fatty acids, cognition and dementia risk: Not just a fishy tale","volume":"81","author":"Saleh","year":"2022","journal-title":"Proc. Nutr. Soc."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/alz.12421","article-title":"Mediterranean and Western diet effects on Alzheimer\u2019s disease biomarkers, cerebral perfusion, and cognition in mid-life: A randomized trial","volume":"18","author":"Hoscheidt","year":"2021","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_163","doi-asserted-by":"crossref","unstructured":"Puranik, N., Kumari, M., Tiwari, S., Dhakal, T., and Song, M. (2025). Resveratrol as a Therapeutic Agent in Alzheimer\u2019s Disease: Evidence from Clinical Studies. Nutrients, 17.","DOI":"10.3390\/nu17152557"},{"key":"ref_164","doi-asserted-by":"crossref","unstructured":"Appiah, D., Ingabire-Gasana, E., Appiah, L., and Yang, J. (2024). The Relation of Serum Vitamin C Concentrations with Alzheimer\u2019s Disease Mortality in a National Cohort of Community-Dwelling Elderly Adults. Nutrients, 16.","DOI":"10.3390\/nu16111672"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"153","DOI":"10.59249\/EWOI2166","article-title":"Therapeutic Potential of Nitrogen-Doped Rutin-Bound Glucose Carbon Dots for Alzheimer\u2019s Disease","volume":"97","author":"Khan","year":"2024","journal-title":"Yale J. Biol. Med."},{"key":"ref_166","doi-asserted-by":"crossref","unstructured":"Ebrahimi, R., Faramarzi, A., Salarvandian, S., Zarei, R., Heidari, M., Salehian, F., and Esmaeilpour, K. (2025). Melatonin Supplementation in Alzheimer\u2019s Disease: The Potential Role in Neurogenesis. Mol. Neurobiol., 1\u201323.","DOI":"10.1007\/s12035-025-05095-x"}],"container-title":["Biomolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-273X\/15\/9\/1345\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:46:08Z","timestamp":1760035568000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-273X\/15\/9\/1345"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,19]]},"references-count":166,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["biom15091345"],"URL":"https:\/\/doi.org\/10.3390\/biom15091345","relation":{},"ISSN":["2218-273X"],"issn-type":[{"value":"2218-273X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,19]]}}}